Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 3Neoplasms 2Malignant Solid Neoplasm 2Lung Neoplasms 2Breast Neoplasms 2Spondylitis, Ankylosing 1Smoking Cessation 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Obesity 1Mouth Neoplasms 1Mental Disorders 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lupus Erythematosus, Systemic 1Localized Head and Neck Carcinoma 1Laryngeal Neoplasms 1Inflammatory Bowel Diseases 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder 1Depression 1Crohn Disease 1Colorectal Neoplasms 1Colitis, Ulcerative 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Reactive × Interviews as Topic × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡